Evidence map›Paper›PMID 36172148›Full record

ArticleFrontiers in oncology2022

Amide proton transfer weighted imaging combined with dynamic contrast-enhanced MRI in predicting lymphovascular space invasion and deep stromal invasion of IB1-IIA1 cervical cancer.

Qingling Song, Shifeng Tian, Changjun Ma, Xing Meng, Lihua Chen, Nan Wang, Liangjie Lin, Jiazheng Wang, Qingwei Song, Ailian Liu

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Qingling SongDepartment of Radiology, First Affiliated Hospital, Dalian Medical University, Dalian, China.
Shifeng TianDepartment of Radiology, First Affiliated Hospital, Dalian Medical University, Dalian, China.
Changjun MaDepartment of Radiology, First Affiliated Hospital, Dalian Medical University, Dalian, China.
Xing MengDepartment of Radiology, Dalian Women and Children's Medical Group, Dalian, China.
Lihua ChenDepartment of Radiology, First Affiliated Hospital, Dalian Medical University, Dalian, China.
Nan WangDepartment of Radiology, First Affiliated Hospital, Dalian Medical University, Dalian, China.
Liangjie LinClinical & Technical Support, Philips Healthcare, Beijing, China.
Jiazheng WangClinical & Technical Support, Philips Healthcare, Beijing, China.
Qingwei SongDepartment of Radiology, First Affiliated Hospital, Dalian Medical University, Dalian, China.
Ailian LiuDepartment of Radiology, First Affiliated Hospital, Dalian Medical University, Dalian, China.
First Affiliated Hospital of Dalian Medical University · CNDalian Medical University · CNPhilips (China) · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: To investigate the value of amide proton transfer weighted (APTw) imaging combined with dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in predicting intermediate-risk factors of deep stromal invasion (DSI) and lymphovascular vascular space invasion (LVSI) in cervical cancer. Methods: Seventy patients with cervical cancer who underwent MRI before operation from July 2019 to February 2022 were retrospectively included in this study. Clinical information including age, histologic subtype etc. were recorded for patients. ATPw imaging parameter APT Results: K Conclusion: The combination of APTw and DCE-MRI is valuable in predicting intermediate-risk factors of DSI and LVSI in cervical cancer.

Indexed as

amide proton transfercervical cancerdeep stromal invasiondynamic contrast-enhancedlymphovascular space invasionMRI

Identifiers

PMID36172148
PMCPMC9512406
OpenAlexW4295271040

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.